{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T02:46:29Z","timestamp":1791341189068,"version":"4.3.1"},"reference-count":36,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81072641"],"award-info":[{"award-number":["81072641"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"National Science and Technology Major Project of China","award":["2011ZX09401-307"],"award-info":[{"award-number":["2011ZX09401-307"]}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"crossref","award":["S2011030003190"],"award-info":[{"award-number":["S2011030003190"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Major Project of Guangdong Province","award":["2008A030201013"],"award-info":[{"award-number":["2008A030201013"]}]},{"DOI":"10.13039\/501100010226","name":"Department of Education of Guangdong Province","doi-asserted-by":"crossref","award":["CXZD1006"],"award-info":[{"award-number":["CXZD1006"]}],"id":[{"id":"10.13039\/501100010226","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1016\/j.bbrc.2012.11.132","type":"journal-article","created":{"date-parts":[[2012,12,19]],"date-time":"2012-12-19T23:29:15Z","timestamp":1355959755000},"page":"944-950","source":"Crossref","is-referenced-by-count":29,"title":["PARP-2 knockdown protects cardiomyocytes from hypertrophy via activation of SIRT1"],"prefix":"10.1016","volume":"430","author":[{"given":"Biao","family":"Geng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanshan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiantao","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peiqing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2012.11.132_b0005","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1161\/01.CIR.0000120390.68287.BB","article-title":"Hypertrophy of the heart: a new therapeutic target","volume":"109","author":"Frey","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.bbrc.2012.11.132_b0010","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0008-6363(00)00076-6","article-title":"Mechanical stress-induced cardiac hypertrophy: mechanisms and signal transduction pathways","volume":"47","author":"Ruwhof","year":"2000","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.bbrc.2012.11.132_b0015","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/j.bbrc.2004.07.121","article-title":"Calcium\u2013calcineurin signaling in the regulation of cardiac hypertrophy","volume":"322","author":"Wilkins","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2012.11.132_b0020","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/nrm1983","article-title":"Regulation of cardiac hypertrophy by intracellular signalling pathways","volume":"7","author":"Heineke","year":"2006","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bbrc.2012.11.132_b0025","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1002\/bies.20085","article-title":"The PARP superfamily","volume":"26","author":"Ame","year":"2004","journal-title":"Bioessays"},{"key":"10.1016\/j.bbrc.2012.11.132_b0030","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/S0006-291X(03)01483-9","article-title":"NAD+ repletion prevents PARP-1-induced glycolytic blockade and cell death in cultured mouse astrocytes","volume":"308","author":"Ying","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2012.11.132_b0035","doi-asserted-by":"crossref","first-page":"4079","DOI":"10.1007\/s00018-012-1003-8","article-title":"Poly(ADP-ribose) polymerase-2: emerging transcriptional roles of a DNA-repair protein","volume":"69","author":"Szanto","year":"2012","journal-title":"Cell Mol. Life Sci."},{"key":"10.1016\/j.bbrc.2012.11.132_b0040","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/nrm1963","article-title":"Poly(ADP-ribose): novel functions for an old molecule","volume":"7","author":"Schreiber","year":"2006","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bbrc.2012.11.132_b0045","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1101\/gad.183509.111","article-title":"On PAR with PARP: cellular stress signaling through poly(ADP-ribose) and PARP-1","volume":"26","author":"Luo","year":"2012","journal-title":"Genes Dev."},{"key":"10.1016\/j.bbrc.2012.11.132_b0050","doi-asserted-by":"crossref","first-page":"6689","DOI":"10.1093\/nar\/gkg890","article-title":"Sensing DNA damage by PARP-like fingers","volume":"31","author":"Petrucco","year":"2003","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbrc.2012.11.132_b0055","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.ceb.2008.03.006","article-title":"Transcriptional control by PARP-1: chromatin modulation, enhancer-binding, coregulation, and insulation","volume":"20","author":"Kraus","year":"2008","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.bbrc.2012.11.132_b0060","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1101\/gad.1331805","article-title":"Poly(ADP-ribosyl)ation by PARP-1: \u2018PAR-laying\u2019 NAD+ into a nuclear signal","volume":"19","author":"Kim","year":"2005","journal-title":"Genes Dev."},{"key":"10.1016\/j.bbrc.2012.11.132_b0065","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1093\/cvr\/cvp144","article-title":"PARP inhibition delays transition of hypertensive cardiopathy to heart failure in spontaneously hypertensive rats","volume":"83","author":"Bartha","year":"2009","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.bbrc.2012.11.132_b0070","doi-asserted-by":"crossref","first-page":"301","DOI":"10.2174\/1570161054368553","article-title":"Pharmacological inhibition of poly(ADP-ribose) polymerase in cardiovascular disorders: future directions","volume":"3","author":"Szabo","year":"2005","journal-title":"Curr. Vasc. Pharmacol."},{"key":"10.1016\/j.bbrc.2012.11.132_b0075","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/j.1527-3466.2007.00018.x","article-title":"Role of poly(ADP-ribose) polymerase 1 (PARP-1) in cardiovascular diseases: the therapeutic potential of PARP inhibitors","volume":"25","author":"Pacher","year":"2007","journal-title":"Cardiovasc. Drug Rev."},{"key":"10.1016\/j.bbrc.2012.11.132_b0080","doi-asserted-by":"crossref","first-page":"43121","DOI":"10.1074\/jbc.M506162200","article-title":"Poly(ADP-ribose) polymerase-1-dependent cardiac myocyte cell death during heart failure is mediated by NAD+ depletion and reduced Sir2alpha deacetylase activity","volume":"280","author":"Pillai","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2012.11.132_b0085","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.molmed.2008.02.003","article-title":"Toward specific functions of poly(ADP-ribose) polymerase-2","volume":"14","author":"Y\u00e9lamos","year":"2008","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.bbrc.2012.11.132_b0090","doi-asserted-by":"crossref","first-page":"17860","DOI":"10.1074\/jbc.274.25.17860","article-title":"PARP-2, A novel mammalian DNA damage-dependent poly(ADP-ribose) polymerase","volume":"274","author":"Ame","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2012.11.132_b0095","doi-asserted-by":"crossref","first-page":"23028","DOI":"10.1074\/jbc.M202390200","article-title":"Poly(ADP-ribose) polymerase-2 (PARP-2) is required for efficient base excision DNA repair in association with PARP-1 and XRCC1","volume":"277","author":"Schreiber","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2012.11.132_b0100","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1093\/hmg\/11.19.2319","article-title":"Poly(ADP-ribose) polymerase 2 localizes to mammalian active centromeres and interacts with PARP-1, Cenpa, Cenpb and Bub3, but not Cenpc","volume":"11","author":"Saxena","year":"2002","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbrc.2012.11.132_b0105","doi-asserted-by":"crossref","first-page":"H1804","DOI":"10.1152\/ajpheart.01078.2007","article-title":"Effects of a Rho kinase inhibitor on pressure overload induced cardiac hypertrophy and associated diastolic dysfunction","volume":"294","author":"Phrommintikul","year":"2008","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.bbrc.2012.11.132_b0110","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.abb.2011.11.024","article-title":"PPARalpha activation inhibits endothelin-1-induced cardiomyocyte hypertrophy by prevention of NFATc4 binding to GATA-4","volume":"518","author":"Le","year":"2012","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.bbrc.2012.11.132_b0115","doi-asserted-by":"crossref","first-page":"2901","DOI":"10.1021\/pr050456l","article-title":"Proteomic analysis of hypertrophied myocardial protein patterns in renovascularly hypertensive and spontaneously hypertensive rats","volume":"5","author":"Zhou","year":"2006","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.bbrc.2012.11.132_b0120","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/S0008-6363(99)00145-5","article-title":"The renin-angiotensin system and experimental heart failure","volume":"43","author":"Wollert","year":"1999","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.bbrc.2012.11.132_b0125","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.cmet.2011.03.013","article-title":"PARP-2 regulates SIRT1 expression and whole-body energy expenditure","volume":"13","author":"Bai","year":"2011","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbrc.2012.11.132_b0130","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1124\/mol.109.056010","article-title":"Peroxisome proliferator-activated receptor (PPAR)-gamma positively controls and PPARalpha negatively controls cyclooxygenase-2 expression in rat brain astrocytes through a convergence on PPARbeta\/delta via mutual control of PPAR expression levels","volume":"76","author":"Aleshin","year":"2009","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bbrc.2012.11.132_b0135","doi-asserted-by":"crossref","first-page":"H1545","DOI":"10.1152\/ajpheart.01124.2005","article-title":"Poly(ADP-ribose) polymerase-1-deficient mice are protected from angiotensin II-induced cardiac hypertrophy","volume":"291","author":"Pillai","year":"2006","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.bbrc.2012.11.132_b0140","doi-asserted-by":"crossref","first-page":"e41545","DOI":"10.1371\/journal.pone.0041545","article-title":"DIOL triterpenes block profibrotic effects of angiotensin II and protect from cardiac hypertrophy","volume":"7","author":"Martin","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrc.2012.11.132_b0145","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1111\/j.1476-5381.2010.00750.x","article-title":"Renin-angiotensin-aldosterone system blockade for cardiovascular diseases: current status","volume":"160","author":"Ma","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bbrc.2012.11.132_b0150","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1002\/j.1460-2075.1993.tb05859.x","article-title":"Overproduction of the poly(ADP-ribose) polymerase DNA-binding domain blocks alkylation-induced DNA repair synthesis in mammalian cells","volume":"12","author":"Molinete","year":"1993","journal-title":"EMBO J."},{"key":"10.1016\/j.bbrc.2012.11.132_b0155","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1093\/emboj\/cdg206","article-title":"Functional interaction between PARP-1 and PARP-2 in chromosome stability and embryonic development in mouse","volume":"22","author":"Menissier de Murcia","year":"2003","journal-title":"EMBO J."},{"key":"10.1016\/j.bbrc.2012.11.132_b0160","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1128\/MCB.24.4.1595-1607.2004","article-title":"Functional interaction between poly(ADP-Ribose) polymerase 2 (PARP-2) and TRF2: PARP activity negatively regulates TRF2","volume":"24","author":"Dantzer","year":"2004","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.bbrc.2012.11.132_b0165","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1146\/annurev.biochem.73.011303.073651","article-title":"The Sir2 family of protein deacetylases","volume":"73","author":"Blander","year":"2004","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.bbrc.2012.11.132_b0170","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1093\/cvr\/cvq376","article-title":"Sirt1 acts in association with PPARalpha to protect the heart from hypertrophy, metabolic dysregulation, and inflammation","volume":"90","author":"Planavila","year":"2011","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.bbrc.2012.11.132_b0175","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1253\/circj.71.397","article-title":"Resveratrol ameliorates experimental autoimmune myocarditis","volume":"71","author":"Yoshida","year":"2007","journal-title":"Circ. J."},{"key":"10.1016\/j.bbrc.2012.11.132_b0180","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.cmet.2011.03.004","article-title":"PARP-1 inhibition increases mitochondrial metabolism through SIRT1 activation","volume":"13","author":"Bai","year":"2011","journal-title":"Cell Metab."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X12023935?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X12023935?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,7]],"date-time":"2020-05-07T06:58:20Z","timestamp":1588834700000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X12023935"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["S0006291X12023935"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2012.11.132","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]}}}